March 18, 2020 at 11:35 JST
Shares in Japan’s Fujifilm Holdings Corp. were untraded at their daily limit high amid a glut of buy orders on Wednesday after a Chinese official said the company’s Avigan anti-flu drug appeared to help coronavirus patients recover.
Avigan, also known as Favipiravir, is manufactured by a subsidiary of Fujifilm, which has a health-care arm though it is better known for its cameras. The treatment was approved for use in Japan in 2014.
Favipiravir has been effective, with no obvious side-effects, in helping new coronavirus patients recover, Zhang Xinmin, an official at China’s Science and Technology Ministry, told reporters at a news conference on Tuesday.
Fujifilm Holdings was not immediately available for comment.
In a clinical trial in Shenzhen involving 80 participants, patients who took Favipiravir showed greater chest improvement and took less time to test negative for the genomic trace of the virus, compared with patients not given the drug, Zhang said.
First developed by Fujifilm Toyama Chemical Co., Ltd., the drug has been approved for manufacturing in China by Zhejiang Hisun Pharmaceutical Co., Ltd., for use against new or recurring influenza in adults, the Chinese drugmaker said in a filing last month.
The Asahi Shimbun aims “to achieve gender equality and empower all women and girls” through its Gender Equality Declaration.
Let’s explore the Japanese capital from the viewpoint of wheelchair users and people with disabilities with Barry Joshua Grisdale.
This special page portrays the dramatic arrest of Carlos Ghosn and the twists and turns that followed.
This special page reviews what the former Nissan Motor Co. chairman left during his 19 years in Japan.
Baseball star Ichiro Suzuki had much to say on March 21, 2019, the day he hung up his spikes.
This special page details how journalists uncovered shady transactions through Bermuda and other tax havens.